封面
市场调查报告书
商品编码
1608867

牛市场:按应用、按最终用户、按地区

Fetal Bovine Serum Market, By Application, By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, and Others), By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3个工作天内

价格
简介目录

牛市场预计到2024年为18.6亿美元,预计到2031年将达到45.4亿美元,2024年至2031年的复合年增长率为13.6%。

分析范围 分析详情
基准年 2023年 市场规模(2024年) 18.6亿美元
实际资料 2019-2023 预测期 2024-2031
预测期复合年增长率(2024-2031) 13.60% 预计金额(2031年) 45.4亿美元
图:2024年按地区牛的胎牛血清市场占有率(%)
胎牛血清市场-IMG1

牛是一种重要的细胞培养基补充品,用于科学研究和各种医疗过程。它源自于从怀孕六个月左右宰杀的怀孕牛身上收集的胎儿血液中获得的胎儿血细胞。牛(FBS) 含有多种对细胞存活、生长和增殖至关重要的生长因子、蛋白质、黏附素和维生素。对生物製药的需求不断增长以及对细胞研究的日益关注正在推动全球牛市场的成长。

市场动态:

全球牛市场的成长是由生物製药需求的增加和生命科学产业研究活动的活性化所推动的。生物製药生产在很大程度上依赖牛来培养和维持最佳的细胞培养条件。慢性病盛行率的不断上升推动了对开发新药的需求,这需要利用牛进行广泛的研究工作。然而,价格波动和对畜牧业动物福利实践的道德担忧可能会阻碍市场成长。此外,向无血清和无异源细胞培养基的转变为牛市场带来了挑战。然而,对个人化医疗、再生疗法和干细胞研究的日益关注预计将在预测期内提供显着的成长机会。

本研究的主要特点

本报告对全球牛市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。

它还阐明了各个细分市场的潜在商机,并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数,提供全球牛市场主要企业的概况。

主要公司包括 Merck KGaA、Thermo Fisher Scientific Inc.、HiMedia Laboratories、Bio-Techne、PAN-Biotech、Atlas Biologicals, Inc.、Rocky Mountain Biologicals、Cytiva、Sartorius AG 和 SeraCare Life Sciences。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本报告针对该产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过分析全球牛市场时所使用的各种策略矩阵来促进决策。

目录

第一章 分析目的与前提

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 企业合併(M&A) 场景
  • 市场趋势

第四章全球牛市场:依应用分类,2019-2031(十亿美元)

  • 药物发现
  • 体外受精
  • 疫苗生产
  • 基于细胞的研究
  • 诊断
  • 其他的

第五章全球牛市场:依最终用户划分,2019-2031 年(十亿美元)

  • 製药和生物技术公司
  • CRO(药物委外研发机构)
  • 学术研究所
  • 其他的

第六章 全球牛市场:依地区划分,2019-2031(十亿美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第七章 竞争格局

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories
  • Bio-Techne
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Cytiva
  • Sartorius AG
  • SeraCare Life Sciences

第八章 分析师建议

  • 《命运之轮》
  • 分析师观点
  • Coherent Opportunity Map (COM)

第9章 参考文献与调查方法

  • 参考
  • 分析方法
  • 关于相干市场洞察
简介目录
Product Code: CMI7483

The fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 4.54 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 1.86 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 13.60% 2031 Value Projection: 4.54 Bn
Figure. Fetal Bovine Serum Market Share (%), By Region, 2024
Fetal Bovine Serum Market - IMG1

Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.

Market Dynamics:

The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fetal bovine serum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market

Market Segmentation

  • Application Insights (Revenue, USD Bn, 2019 - 2031)
    • Drug Discovery
    • In-vitro Fertilization
    • Vaccine Production
    • Cell-based Research
    • Diagnosis
    • Others
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations (CRO)
    • Academic And Research Institutes
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • HiMedia Laboratories
    • Bio-Techne
    • PAN-Biotech
    • Atlas Biologicals, Inc.
    • Rocky Mountain Biologicals
    • Cytiva
    • Sartorius AG
    • SeraCare Life Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fetal Bovine Serum Market, By Application
    • Fetal Bovine Serum Market, By End User
    • Fetal Bovine Serum Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Market Trends

4. Global Fetal Bovine Serum Market, By Application, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • In-vitro Fertilization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Vaccine Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cell-based Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Fetal Bovine Serum Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic And Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Fetal Bovine Serum Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • HiMedia Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Cytiva
  • Sartorius AG
  • SeraCare Life Sciences

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us